Here's What I Think Is Going on With Palantir Stock After Its Recent Slide

Palantir reported first-quarter revenue growth of 85% year over year to $1.63 billion, raised full-year 2026 revenue guidance to $7.65 billion-$7.66 billion, and posted a 60% adjusted operating margin. However, the stock remains down about 23% year to date and still trades at an elevated valuation of roughly 66 times sales and around 100 times forward earnings. The article argues the business is excellent, but the stock may need time to grow into its premium multiple.

Analysis

The market is no longer debating whether PLTR is a real business; it is debating whether the current growth rate is investable at scale. The core second-order issue is multiple compression: once a software name trades at a valuation that already discounts several years of hypergrowth, each incremental beat has to arrive earlier and larger just to prevent de-rating. That makes the stock unusually sensitive to any sign of deceleration in the U.S. commercial engine or a plateau in net retention, even if the fundamental trajectory remains excellent.

The most important competitive implication is not that a single rival displaces Palantir, but that hyperscalers and horizontal AI platforms can erode pricing power over time. If customers can stitch together sufficient functionality from existing cloud/AI stacks, PLTR’s premium becomes harder to defend because the market will start capitalizing gross growth less and operating leverage more conservatively. That dynamic also matters for other software names: the tighter investors become on PLTR, the more scrutiny spreads across high-multiple AI beneficiaries, especially those without clear mission-critical workflows or durable contract value.

The setup is asymmetric over different horizons. In the next few weeks, the stock can continue to underperform simply because valuation anchors are now lower but still extreme, and post-earnings momentum is vulnerable to a “great numbers, bad stock” regime. Over 3-6 months, the main catalyst is whether the company can show that the international commercial segment re-accelerates and that U.S. growth remains demand-constrained rather than just comparison-driven. A sharp upside re-rate likely requires either another step-function raise in guidance or proof that monetization is broadening beyond the current core customer cohort.

The contrarian view is that consensus may be underestimating how long PLTR can remain structurally expensive if the business keeps compounding at 70%+ with 60% operating margins. At this pace, the company could still grow into the multiple faster than bears expect, but only if execution stays nearly flawless. The risk/reward is therefore not in calling for a collapse; it is in positioning for continued volatility and mean reversion around an elevated but fragile valuation floor.

Key Decisions for Investors

• Short PLTR on rallies into earnings or guidance events over the next 1-2 quarters; use tight risk control because fundamentals can still overpower valuation in the short run, but expect 10-20% downside on any sign of deceleration or conservative commentary.
• Prefer a pair trade: long NVDA / short PLTR for 1-3 months if you want exposure to AI spend with better valuation support; NVDA benefits from broader infrastructure demand while PLTR is more exposed to software multiple compression.
• Buy PLTR put spreads 60-120 days out, ideally financed on strength; structure for a 2:1 to 3:1 payoff if the market begins to haircut the growth story from hypergrowth to merely elite growth.
• For long-only accounts, wait for a post-earnings shakeout or a further 10-15% drawdown before initiating; the stock needs time to prove it can digest its own expectations, and chasing here leaves poor asymmetry.
• Monitor international commercial growth and remaining deal value over the next two quarters; if either slows materially, add to short exposure because that would signal the multiple is losing its last fundamental support.